版本:
中国

Merck's revenue rises 1.3 pct

May 2 Merck & Co Inc reported a 1.3 percent rise in quarterly revenue, helped by higher demand for its key immuno-oncology drug Keytruda.

Net income attributable to Merck rose to $1.55 billion, or 56 cents per share, in the first quarter, from $1.13 billion, or 40 cents per share, a year earlier.

Total revenue climbed to $9.43 billion from $9.31 billion. (Reporting by Natalie Grover; Editing by Savio D'Souza)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐